Elbit Imaging Ltd.

Elbit Imaging Ltd.

EMITF
Elbit Imaging Ltd.US flagOther OTC
1.60
USD
- -
- -
21.25MMarket Cap
Elbit Imaging Ltd.
EMITF
(Other OTC)

Recent

price

1.60

P/E

ratio

- -

div

yld

- -

ROIC.AI

2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
TTM
FRC
1,383.06
1,145.74
73.24
4.74
50.35
25.27
- -
- -
- -
- -
- -
- -
- -
- -
- -
3.06
4.14
Revenue per Share
147.08
-638.8
-761.26
-2,784.91
127.46
-23.51
-21.2
-36.78
-56.34
-11.7
25.01
-2.24
-0.26
-0.27
-0.5
-0.43
-0.41
Basic EPS, GAAP
-963.04
-663.83
-12.83
33.51
34.94
21.18
8.07
46.75
-2.21
-1.61
-1.7
-0.37
-0.04
-0.04
-0.05
0.54
-0.19
Free Cash Flow per Basic Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
0.27
1.11
0.14
- -
- -
- -
Dividend per Share
- -
647.36
287.62
-384.61
124.8
111.32
76.08
73.51
17.45
5.79
30.8
28.35
27.53
-0.89
5.43
5.45
5.79
Book Value per Share
5,165.93
3,531.22
3,313.7
-2,488.49
29.31
38.4
5.29
-16.19
-6.54
-18.41
10.28
7.74
6.92
-0.07
6.42
7.06
7.27
Tangible Book Value per Share
- -
- -
- -
- -
8
8
9
9
9
9
9
9
9
10
11
12
13
Basic Weighted Avg Shares
583
475
30
2
399
200
- -
- -
- -
- -
- -
- -
- -
- -
- -
38
55
Sales/Revenue/Turnover
-30.52
-41.85
-67.05
-2,900.71
-26.84
-53.46
- -
- -
- -
- -
- -
- -
- -
- -
- -
-6.29
2.07
Operating Margin (%)
115
339
10
4
583
123
196
120
113
- -
- -
- -
- -
- -
- -
- -
- -
Depreciation Expense
62
-265
-316
-1,156
1,009
-186
-195
-338
-518
-107
230
-20
-2
-3
-5
-5
-5
Net Income, GAAP
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Effective Tax Rate (%)
10.63
-55.75
-1,039.36
-58,811.45
253.15
-93.04
- -
- -
- -
- -
- -
- -
- -
- -
- -
-14.03
-9.93
Profit Margin (%)
3,681
-969
-704
-2,694
102
-589
-1,031
-363
-110
-108
-3
21
35
- -
68
-18
57
Working Capital
- -
6,355
3,669
- -
756
1,444
853
243
145
159
- -
- -
- -
2
2
71
137
LT Debt
2,178
1,539
1,421
-1,033
232
304
49
-149
-60
-169
94
71
63
-1
68
87
97
Total Equity
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Invested Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Capital (%)
9.53
-197.35
-162.85
- -
- -
-19.92
-24.65
-49.17
-123.88
-100.66
136.71
-7.55
-0.93
-7.47
- -
-8.47
-14.22
Return on Common Equity (%)

Capital Structure

FRC

in mil. unless spec.
Sep'25
Dec'25
Mar'26
ST Debt
187
172
125
LT Borrowings
71
71
137
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
13
13
13
Market Capitalization
70
2
75

Working Capital

FRC

in mil. unless spec.
Sep'25
Dec'25
Mar'26
Total Current Assets
204
194
214
Cash, Cash Equivalents & STI
149
145
163
Accounts Receivable, Net
3
- -
4
Inventories
- -
- -
- -
Total Current Liabilities
224
212
157
Payables & Accruals
- -
- -
- -
ST Debt
187
172
125
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
-1,055.57%
-2,006.34%
27.1%
Free Cash Flow
- -
- -
-1,244.16%
Net Income, GAAP
-34.59%
-16.83%
-0.71%
Sales/Revenue/Turnover
- -
- -
-81.16%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
24
14
38
2026
17
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
-0.06
- -
- -
-0.5
2025
-0.15
- -
-0.15
- -
-0.43
2026
-0.13
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -
Business
Elbit Imaging Ltd. operates as an Israeli holding entity with a diversified portfolio spanning real estate and advanced medical industries. Through its various subsidiaries, the company is actively engaged in the research, development, production, and global distribution of sophisticated therapeutic medical systems. These innovative solutions leverage magnetic resonance imaging (MRI)-guided focused ultrasound technology for non-invasive treatments across the human body. Furthermore, its medical industry interests include the advancement of stem cell population expansion technologies and the creation of stem cell therapy products, intended for transplantation and regenerative medicine to address various conditions such as certain types of cancer and blood disorders. The geographical reach for its medical systems extends across North and South America, Europe, Asia, and Oceania. Concurrently, the company maintains substantial involvement in real estate, encompassing the initiation, construction, and sale of commercial centers, hotel operations, and residential developments. These property ventures are primarily concentrated in Central and Eastern Europe and India, with a focus on plots designated for residential projects. Founded in 1996, Elbit Imaging Ltd. is headquartered in Petach Tikva, Israel.